secwatch.observer — SEC 8-K summary
======================================

Issuer:     Omega Therapeutics, Inc. (—)
CIK:        0001850838
Form:       8-K
Filed at:   2025-02-14T23:59:59+00:00
Accession:  0001193125-25-027349
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.01, 1.03, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Omega Therapeutics files for Chapter 11 bankruptcy with $9.8M DIP financing
---------------------------------------------------------------------------

- Filed voluntary Chapter 11 petition on February 10, 2025 in Delaware Bankruptcy Court.
- Received interim approval for $9,820,908 DIP facility from Flagship affiliate; $3,931,953 funded Feb 13.
- DIP includes roll-up of $1,475,178 prepetition note plus $165,000 fees; 10% interest, matures 70 days post-petition.
- Court-approved milestones: final DIP order by day 30; asset sale order by day 60; closing by day 70.
- Company remains debtor-in-possession; Flagship entities are significant stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850838/000119312525027349/0001193125-25-027349-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850838/000119312525027349/d896578d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-027349

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer